PANK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.653600E-01
Normal-vs-Stage2
6.753200E-01
Normal-vs-Stage3
1.463400E-01
Normal-vs-Stage4
4.671800E-01
Stage1-vs-Stage2
2.815400E-01
Stage1-vs-Stage3
1.769650E-02
Stage1-vs-Stage4
8.580600E-01
Stage2-vs-Stage3
3.55059981416161E-10
Stage2-vs-Stage4
2.444800E-01
Stage3-vs-Stage4
1.997030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.270000E-01
Normal-vs-AfricanAmerican
3.595800E-01
Normal-vs-Asian
6.225400E-01
Caucasian-vs-AfricanAmerican
3.469200E-01
Caucasian-vs-Asian
9.124400E-01
AfricanAmerican-vs-Asian
5.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.595000E-01
Normal-vs-Female
6.997200E-01
Male-vs-Female
3.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.351220E-01
Normal-vs-Age(41-60Yrs)
4.525200E-01
Normal-vs-Age(61-80Yrs)
7.470000E-01
Normal-vs-Age(81-100Yrs)
6.529400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.657400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.921000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.351800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.124300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.937800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.105600E-01
Normal-vs-Daily Drinker
6.725600E-01
Normal-vs-Weekly Drinker
7.308000E-01
Normal-vs-Occasional Drinker
4.276600E-01
Normal-vs-Social Drinker
6.918600E-01
Non Drinker-vs-Daily Drinker
8.113200E-01
Non Drinker-vs-Weekly Drinker
1.533030E-01
Non Drinker-vs-Occasional Drinker
2.073000E-01
Non Drinker-vs-Social Drinker
7.028200E-01
Daily Drinker-vs-Weekly Drinker
1.564580E-01
Daily Drinker-vs-Occasional Drinker
2.887800E-01
Daily Drinker-vs-Social Drinker
8.673000E-01
Weekly Drinker-vs-Occasional Drinker
3.859700E-02
Weekly Drinker-vs-Social Drinker
2.603400E-01
Occasional Drinker-vs-Social Drinker
4.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.176200E-01
Normal-vs-Grade 2
4.555400E-01
Normal-vs-Grade 3
3.932400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.096200E-01
Grade 1-vs-Grade 3
6.732600E-01
Grade 1-vs-Grade 4
3.176200E-01
Grade 2-vs-Grade 3
9.209000E-01
Grade 2-vs-Grade 4
4.555400E-01
Grade 3-vs-Grade 4
3.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.089600E-01
Normal-vs-NonDiabetic
6.077400E-01
Diabetic-vs-NonDiabetic
2.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.949400E-01
Normal-vs-NoPancreatitis
6.209400E-01
Pancreatitis-vs-NoPancreatitis
7.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.723600E-01
Normal-vs-N1
6.444200E-01
N0-vs-N1
7.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.785600E-01
Normal-vs-TP53-NonMutant
3.013400E-01
TP53-Mutant-vs-TP53-NonMutant
3.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
